EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration

Hao Zhou, Shengjun Li, Yuansheng Lin

PeerJ · 2023

DOI: 10.7717/peerj.15238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Hao Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, Chin…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Through analyzing the SH2D5 expression profiles, clinical features, and immune infiltration in lung adenocarcinoma (LUAD), the study was intended to discuss the correlations of SH2D5 with prognosis and immune infiltration in LUAD.

Methods

We downloaded transcriptome and clinical data of LUAD patients from TCGA, GEO, and CCLE databases. Sangerbox, R language, GEPIA, UALCAN, and Kaplan-Meier Plotter were adopted to analyze the SH2D5 expression patterns, prognosis, and clinical features. Spearman correlation analysis was performed to determine the association between SH2D5 expression and immune cell infiltration and immune checkpoint genes. The miRNA-SH2D5 relations were predicted by miRDB and starbase. Lastly, quantitative PCR, IHC and Western blot were implemented for validation.

Results

A prominent up-regulation of SH2D5 was noted in the LUAD group relative to the normal group, which was validated by quantitative PCR, IHC and Western blot. SH2D5 expression was inversely related to overall survival (OS) of LUAD patients as well as B cell immune infiltration. Additionally, SH2D5 expression was negatively correlated with dendritic cells resting ( p < 0.001), plasma cells ( p < 0.001), mast cells resting ( p = 0.031) and T cells CD4 memory resting ( p = 0.036) in LUAD patients with abundant SH2D5 expression correlated with poor prognosis. Furthermore, enrichment analysis suggested that SH2D5 was associated with lung cancer and immunity. Lastly, we investigated the relationship between the expression of SH2D5 and the use of antitumor drugs.

Conclusion

High SH2D5 expression shares an association with unfavorable prognosis in LUAD, and SH2D5 may also provide new ideas for immunotherapy as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsMicroRNAsHumansMast CellsPrognosisShc Signaling Adaptor Proteins

Stichwörter der Autor:innen

Immune infiltrationLung adenocarcinomaPrognosisSH2D5

Substanzen

MicroRNAsShc Signaling Adaptor ProteinsSH2D5 protein, human

Autor:innen und Institutionen

  • Department of Emergency and Critical Care Medicine, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.

Zitieren

APA

Zhou, H., Li, S., & Lin, Y. (2023). Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration. PeerJ. https://doi.org/10.7717/peerj.15238

Vancouver

Zhou H, Li S, Lin Y. Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration. PeerJ. 2023. doi:10.7717/peerj.15238

BibTeX
@article{Zhou2023,
  author = {Zhou, Hao and Li, Shengjun and Lin, Yuansheng},
  title = {Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.15238}
}
Kostenlos starten →